llm_output,best_matching_ground_truth,best_evaluation,best_score
ketamine highly effective treatment-resistant unipolar depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct but misses the mention of bipolar depression in the ground truth statement.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM Output only partially captures the Ground Truth statement by mentioning SSRIs but fails to accurately convey the concept of Norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.5
monoamine oxidase inhibitors (maois) less commonly used over the years,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct as it acknowledges that monoamine oxidase inhibitors are less commonly used now, but it doesn't explicitly state that they are a form of pharmacotherapy.",0.75
serotonin-norepinephrine reuptake inhibitors (snris) second-line treatment patients who do not respond to ssris,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.80
The LLM output is mostly correct in capturing the essence of the ground truth statement, but with slight differences in wording.",0.8
monoamine oxidase inhibitors (maois) more effective depression with atypical features,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is somewhat related to the ground truth by discussing the effectiveness of monoamine oxidase inhibitors in depression, but it inaccurately claims they are more effective for depression with atypical features.",0.75
ketamine not effective as a miracle drug for all depression cases,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is partially correct as it mentions ketamine not being effective for all depression cases, but it does not directly address the eligibility of monoamine oxidase inhibitors for patients who do not respond to other treatments.",0.75
electroconvulsive therapy (ect) highly effective depression in some specific situation,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is mostly correct in mentioning electroconvulsive therapy as a treatment option for depression, but lacks the comprehensive information provided in the Ground Truth statement.",0.75
"ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blur vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM Output is identical to the Ground Truth with no errors in the list of side effects.",1.0
tricyclic antidepressants (tcas) comparable to monoamine oxidase inhibitors (maois) and ssris,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct as it identifies tricyclic antidepressants and SSRIs as other types of pharmacotherapy for depression, but it incorrectly states that they are comparable to MAOIs.",0.75
ketamine highly effective treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct as it highlights the effectiveness of ketamine in treating depression, but it is not specific about the types of depression it is effective for.",0.75
"venlafaxine side effects nausea, vomiting, and sexual dysfunction",Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output switched the medication mentioned from fluoxetine to venlafaxine, but accurately identified common side effects such as nausea, vomiting, and sexual dysfunction.",0.75
psychotherapy treats all depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is only partially correct as it incorrectly states that psychotherapy treats all depression, while the ground truth specifies that pharmacotherapy treats the acute phase of depression.",0.5
cognitive behavioral therapy (cbt) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is largely correct, but misses some details such as specifying ""depression-focused"" and using the acronym ""MDD"" instead of ""major depressive disorder.""",0.9
selective serotonin reuptake inhibitor (ssri) definition a class of antidepressant known to improve tolerability with several minor side effects,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output provides some relevant information about SSRIs and their side effects, but does not accurately reflect the activating profile of bupropion compared to SSRIs in patients with Major Depressive Disorder (MDD).",0.75
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct but lacks the specific mention of ""depression-focused psychotherapy"" mentioned in the ground truth.",0.75
"fluoxetine side effects sexual dysfunction, loss of appetite, vomiting, nausea, irritability, anxiety, insomnia, and headache",Duloxetine Side effects Lower acceptability,"Score: 0.75
The LLM output contains accurate information about the side effects of fluoxetine, but does not directly address the comparison with duloxetine.",0.75
monoamine oxidase inhibitor (maoi) definition a class of antidepressant that confirms the role of monoaminergic transmission in depression,Psycho-education Goal Educates depressed patients and family members involved in the patient’s life about depression symptoms and management,"Score: 0.75
The LLM output provides some relevant information about antidepressants and depression, but deviates from the original ground truth by not directly addressing psycho-education goals for depressed patients and family members.",0.75
depression definition a common psychiatric disorder and a major contributor to the global burden of disease,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct as it accurately describes depression as a common psychiatric disorder, but it does not mention depression-focused psychotherapy or its role as the second most common treatment for acute phase depression.",0.75
electroconvulsive therapy (ect) first-line treatment resistant depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy as a treatment option for depression, but inaccurately suggests it is a first-line treatment for resistant depression.",0.75
vagus nerve stimulation (vns) definition therapeutic method for resistant unilateral or bipolar depression,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.75
The LLM output is mostly correct in identifying vagus nerve stimulation as a therapeutic method for depression, but it does not directly address the goal of reducing or stopping antidepressant treatment without increasing the risk of depressive recurrence.",0.75
repetitive transcranial magnetic stimulation (rtms) more effective placebo condition,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.70
The LLM output is partially correct, as it correctly mentions rTMS but incorrectly identifies it as more effective than placebo, lacking information on other somatic treatments.",0.7
transcranial direct current stimulation (tdcs) less effective antidepressant,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies transcranial direct current stimulation as a somatic treatment, but the statement that it is less effective as an antidepressant is not entirely accurate as it can be effective for some individuals.",0.75
magnetic seizure therapy comparable to ect,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.85

The LLM output is mostly correct as it correctly identifies magnetic seizure therapy as a somatic treatment, but it misses the comparison to electroconvulsive therapy (ECT) which is also a form of somatic treatment.",0.85
cognitive behavioral therapy (cbt) definition a psychotherapeutic method based on modifying dysfunctional behavior and cognition,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output correctly identifies cognitive-behavioral therapy as a psychotherapeutic method focusing on modifying dysfunctional behavior and cognition, but it lacks specificity by not mentioning depression, irrational beliefs, or challenging/reversing distorted cognitions.",0.75
anxious depression more common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not directly related to the ground truth statement, so it only receives a moderate score for correctness.",0.5
vortioxetine treats major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is not correct as it is talking about a different treatment (vortioxetine for major depressive disorder), which is unrelated to the ground truth statement about schema therapy for personality disorder comorbidity.",0.25
electroconvulsive therapy (ect) results reduced number of hospital readmissions,Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.90
The LLM output captures the essence of the ground truth statement but fails to capitalize the abbreviation ""ECT"" and has a minor word order issue.",0.9
deep brain stimulation (dbs) benefits patient with resistant depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly mentions deep brain stimulation (DBS) as a somatic treatment for depression, but it does not encompass the full range of somatic treatments mentioned in the ground truth.",0.75
intranasal esketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is partially correct as it mentions a specific treatment for a type of depression, but it does not directly relate to the ground truth statement about treating the acute phase of depression.",0.75
mirtazapine treats major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is not correct as it discusses a different treatment for a different mental health condition compared to the ground truth.",0.25
ketamine definition a treatment associated with rapid effects on resistant depression and acute suicidal ideation but has short antidepressant effect and possible neurotoxicity and drug dependence,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in its discussion of ketamine's effects on depression and suicidal ideation, but it does not specifically mention pharmacotherapy as a treatment for the acute phase of depression.",0.75
ketamine associated with risk of misuse,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output does not directly address the information in the Ground Truth statement, so it is only partially correct.",0.5
phototherapy (luxtherapy) specific efficacy in treating seasonal and non-seasonal depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.75
Explanation: The LLM output captures the main idea of the ground truth but lacks specificity in mentioning benefits to sleep deprivation and drug treatments.",0.75
"mirtazapine, escitalopram, venlafaxine, sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output contains some accurate information by correctly listing escitalopram and sertraline as SSRIs, but it also includes other antidepressants that are not in the SSRI class.",0.5
reboxetine less effective all the other antidepressants tested,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output is partially incorrect as it focuses on one antidepressant (reboxetine) being less effective, while the ground truth statement is about rTMS and antidepressants being more effective overall.",0.5
nefazodone side effects clinical hepatotoxicity,Nefazodone Side effects Rare cases of clinical idiosyncratic hepatotoxicity,"Score: 0.80
The LLM output captures the key information about the side effects of nefazodone, but misses the mention of it being rare and idiosyncratic.",0.8
"escitalopram and sertraline more effective duloxetine, fluvoxamine, paroxetine, reboxetine, venlafaxine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies some antidepressants as more effective than others but misses the key point that repetitive Transcranial Magnetic Stimulation (rTMS) is more effective than any of the listed antidepressants.",0.75
escitalopram more effective citalopram,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies the comparison between escitalopram and citalopram, but does not mention repetitive Transcranial magnetic stimulation and antidepressants as being more effective.",0.75
mirtazapine more effective fluoxetine,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that mirtazapine is more effective than fluoxetine, but it incorrectly suggests this comparison as opposed to SSRIs in general.",0.75
citalopram more effective reboxetine,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output does not accurately reflect the ground truth, as it states citalopram and reboxetine as more effective, while the ground truth indicates rTMS and antidepressants in general as more effective.",0.5
sertraline more effective fluoxetine,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output partially captures the idea of antidepressants being compared for effectiveness, but lacks the specific mention of repetitive Transcranial Magnetic Stimulation (rTMS) and the comparison to it.",0.5
venlafaxine more effective fluvoxamine,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM Output is partially correct as it mentions two antidepressants, but it does not match the ground truth that rTMS is more effective than antidepressants.",0.5
mirtazapine more effective venlafaxine,Mirtazapine As effective as SSRIs,"Score: 0.50
The LLM output incorrectly states that mirtazapine is more effective than venlafaxine, which goes against the ground truth statement comparing mirtazapine to SSRIs.",0.5
reboxetine less effective all antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output is partially correct in mentioning that reboxetine is less effective than other antidepressants, but it misses the key point that rTMS is actually more effective than antidepressants overall.",0.5
electroconvulsive therapy (ect) treats major depressive disorder,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output is partially correct in identifying a treatment for major depressive disorder, but it is not the same as the ground truth statement which specifically mentions cognitive-behavioral therapy for depressed patients with irrational beliefs and distorted cognitions.",0.75
"escitalopram more effective duloxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identified different antidepressants as being effective, but did not specifically mention repetitive Transcranial magnetic stimulation (rTMS) as more effective.",0.75
electroconvulsive therapy (ect) first-line treatment suicidality in mdd,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as a treatment option for depression, but incorrectly suggests it as a first-line treatment for suicidality in major depressive disorder (MDD).",0.75
sertraline good choice moderate to severe major depression,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output correctly identifies sertraline as a treatment option for moderate to severe major depression, but it inaccurately presents it as a good choice for mild to moderate MDD.",0.75
electroconvulsive therapy (ect) widely used neuro-modulation treatment for depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is partially correct as electroconvulsive therapy is a treatment for depression but it is not specifically mentioned in the ground truth in relation to marital and family therapy.",0.75
selective serotonin reuptake inhibitors (ssris) example antidepressants,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.50
The LLM output is only partially correct as it mentions selective serotonin reuptake inhibitors instead of monoamine oxidase inhibitors and tricyclic antidepressants.",0.5
sertraline more effective other new-generation antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output partially captures the main idea by mentioning antidepressants, but incorrectly focuses on sertraline and does not mention rTMS.",0.5
major depressive disorder example depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output does not accurately represent the Ground Truth, as it only mentions depression in general while the Ground Truth specifies problem-solving therapy and treating elderly patients with mild depressive symptoms.",0.5
sertraline benefits moderate to severe major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output correctly mentions the benefits of sertraline for major depression in adults, but it does not fully capture the comparison between bupropion and SSRIs as stated in the ground truth.",0.75
6-24 weeks follow-up duration associated with variability in treatment outcomes,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.75
The LLM output correctly identifies the variability in treatment outcomes with different follow-up durations, but does not fully capture the specific findings of the ground truth statement.",0.75
anxious depression subset major depressive disorder,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.25
The LLM output does not accurately capture the information in the Ground Truth statement, as it only partially relates to depression and does not mention problem-solving therapy or preventing depression among the elderly.",0.25
sponsorship bias associated with pharmaceutical company involvement in clinical trials,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not correct as it does not accurately reflect the information in the ground truth statement about problem-solving therapy and its use in preventing and treating depression among the elderly.",0.5
sertraline first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50

The LLM output is somewhat related to the ground truth in that it mentions a first-line treatment for major depressive disorder, but it does not address the specific goal of reducing or stopping antidepressant treatment with mindfulness-based cognitive therapy.",0.5
"physical exercise definition an adjunct therapy recommended for alleviating depression symptoms and preventing relapse, improving quality of life",Pharmacotherapy Treats Acute phase of depression,"Score: 0.80

The LLM output touches on the treatment of depression with physical exercise as an adjunct therapy, but misses the mention of pharmacotherapy as a primary treatment for the acute phase of depression.",0.8
nonanxious depression subset major depressive disorder,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output contains some relevant keywords related to depression, but does not accurately reflect the ground truth of problem-solving therapy for preventing depression among the elderly and treating patients with mild depressive symptoms.",0.5
citalopram first-line treatment major depressive disorder in star*d level 1,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output does not accurately reflect the ground truth as it mentions citalopram for major depressive disorder instead of problem-solving therapy for preventing depression among the elderly and treating mild depressive symptoms.",0.5
major depressive disorder symptom anxiety and nervousness,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.50
The LLM output correctly identifies some symptoms related to major depressive disorder, but misses the main focus of the ground truth statement which is about cognitive-behavioral therapy for depressed patients with irrational beliefs and distorted cognitions.",0.5
reboxetine not effective acute treatment for major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it highlights reboxetine's ineffectiveness for acute treatment of major depression, aligning with the ground truth statement. However, the lack of specificity in mentioning other potential pharmacotherapies limits the score slightly.",0.75
cognitive behavioral therapy (cbt) definition a type of psychotherapy,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct in identifying cognitive-behavioral therapy as a type of psychotherapy but lacks specificity in mentioning other types of therapies included in depression-focused psychotherapy.",0.75
early response to antidepressants definition improvement in symptoms within a predefined follow-up duration,"Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.70

The LLM output is somewhat relevant to the ground truth in terms of addressing symptoms, but it focuses more on early response to medication rather than a holistic approach to depression-focused psychotherapy.",0.7
mindfulness-based cognitive therapy (mbct) definition combines elements of cbt with mindfulness-based stress reduction,Mindfulness-based cognitive therapy Combines CBT with mindfulness-based stress reduction,"Score: 0.90
The LLM output is highly accurate but slightly paraphrased from the ground truth.",0.9
anxious depression results more serious adverse events,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.25
The LLM output is not correct as it is providing information about anxious depression and serious adverse events, which is unrelated to the original statement about the effectiveness of repetitive transcranial magnetic stimulation compared to antidepressants.",0.25
"anxious depression more common than nonanxious depression in african american group, hispanics, primary care patients, unemployed, married then divorced/widowed, less education, public insurance, lower-income",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50

The LLM output is only partially correct as it focuses on specific demographics and characteristics associated with anxious depression rather than addressing depression-focused psychotherapy as the second most common treatment of Acute phase depression.",0.5
anxious depression more common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not directly related to the ground truth statement.",0.5
sustain-release bupropion dosage maximal daily dose of 400 mg,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output provides information about the dosage of sustained-release bupropion but does not address the comparison with SSRIs for improving symptoms of fatigue and sleepiness.",0.5
buspirone dosage dose of up to 60 mg per day,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is incorrect as it is providing information on buspirone dosage instead of comparing bupropion and SSRIs for improving symptoms of fatigue and sleepiness.",0.5
benzodiazepine treats insomnia and agitation,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.25
The LLM output is not correct as it mentions benzodiazepine treating insomnia and agitation, while the ground truth talks about marital and family therapy treating severe forms of depression associated with medications and hospitalization.",0.25
mirtazapine among the most efficacious treatments acute treatment of major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output is mostly correct but adds specific information about mirtazapine, which may not apply to all pharmacotherapy treatments for acute phase depression.",0.8
anxious depression associated with poor acute outcome following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is generally correct in capturing the relationship between depression and treatment outcomes, but it also introduces the concept of anxiety and does not specifically mention a slower response to treatment.",0.75
anxious depression definition major depression with anxious features,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is only partially correct as it mentions depression, but does not accurately reflect the ground truth statement about problem-solving therapy for preventing and treating depression in the elderly.",0.5
citalopram treats anxious and nonanxious major depressive disorder in star*d level 1,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is not correct as it mentions citalopram treating major depressive disorder, while the ground truth statement specifically discusses monoamine oxidase inhibitors treating atypical features.",0.5
anxious depression associated with longer time to remission or response,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in capturing the idea that depression can lead to a slower response to treatment, but it adds the additional information that anxious depression specifically is associated with longer time to remission or response.",0.75
placebo-controlled trial requirements marketing authorization for antidepressants in the usa and europe,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50

The LLM output is somewhat relevant to antidepressants, but it does not accurately reflect the information provided in the Ground Truth statement about the specific efficacy of monoamine oxidase inhibitors in treating atypical features.",0.5
citalopram symptom worsening of insomnia and nervousness,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output mentions citalopram worsening symptoms of insomnia and nervousness, which is somewhat relevant to the ground truth but not completely accurate.",0.5
anxious depression results significantly lower remission rates and longer time to remission than nonanxious depression,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
The LLM output is mostly correct in identifying differences in remission rates and time to remission between anxious and nonanxious depression, but it does not directly compare to transcranial direct current stimulation, antidepressants, and rTMS as stated in the ground truth.",0.8
anxious depression associated with greater severity of depressive illness and functional impairment,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.60
The LLM output captures some aspects of depression but does not accurately reflect the statement about marital and family therapy being used to treat severe forms of depression associated with medications and hospitalization.",0.6
"anxious depression results greater frequency, intensity, and burden of side effects",Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.75
The LLM output is mostly correct in identifying the effects of transcranial direct current stimulation on anxious depression, but misses the point about outperforming the simulator in terms of rate of response and remission.",0.75
